SR

Shivlal Ramjibhai Barejia

Active Director Director DIN 09608161
DIN 09608161 First appointment May 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shivlal Ramjibhai Barejia

Data last updated:

Shivlal Ramjibhai Barejia is a Director at Pharmagic Lifesciences Private Limited (since 2022). The company operates in Healthcare.

DIN 09608161
Primary Designation Director
Industry Healthcare
First Appointment 17 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 20222021Active

Directorship timeline

Open interactive timeline →
Pharmagic Lifesciences Private Limited
Premium access

Shareholding and investment profile for Shivlal Ramjibhai Barejia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivlal Ramjibhai Barejia

Shivlal Ramjibhai Barejia currently holds 1 directorship: Pharmagic Lifesciences Private Limited (Director, since 17 May 2022).

Shivlal Ramjibhai Barejia was first appointed on 17 May 2022 as Director at Pharmagic Lifesciences Private Limited.

The current boards of Shivlal Ramjibhai Barejia's companies include Chirag Jitendrabhai Sadhariya (Pharmagic Lifesciences Private Limited), Neimish Bharatbhai Ruparelia (Pharmagic Lifesciences Private Limited), Pankajkumar Popatbhai Sankhavara (Pharmagic Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available